No publication covers cancer research and drug development as comprehensively as Cancer Weekly.
Not only does Cancer Weekly bring you more reports, but more coverage of every aspect of cancer research, from drug candidate identification through launch and beyond.
Published weekly, each issue of Cancer Weekly has more than 400 articles that cover cancer diseases and research A-Z, including cancers of all types, oncology, cancer vaccines and antibodies, antisense technology, cancer genetics and genomics, diagnostics, and associated drug development.
But important cancer research news is only half the picture. Cancer Weekly also provides key business intelligence regarding marketing, distribution, licensing, regulatory actions, personnel and funding for the pharmaceutical and biotech companies involved in cancer research and drug manufacturing.
NewsRx editors collect coverage from more than 4,000 peer-reviewed journals, dozens of industry meetings, medical news wires, pharmaceutical and biotech company internet sites, purchased databases, and press releases.
Each article, usually no more than 500 words, is written to be an information-heavy, concise report of the pertinent facts, together with full references and citations for original source material. You get a fast, user-friendly read that keeps you on top of all the important cancer research-related developments for that week.
Cancer Weekly is available in print or online at www.NewsRx.com. Email versions can be delivered directly to your desktop. Site licenses are also available for corporate use.
Combination print and email subscriptions are available, and all subscriptions come with online access to Cancer Weekly's archives, which go back to 1995. See a sample issue here.
NewsRx first published Cancer Weekly in 1988, and it quickly became the leading cancer research newsletter. We stake our 20-plus year history as a publisher that it remains the best.
But don't take our word for it. Sign up for our six-week, no-risk free trial and see for yourself. Receive six issues of Cancer Weekly, more than 1,000 articles, and see why it will become your indispensable tool for tracking cancer research news and developments.
Subscribe now and we'll give you $300 off our regular subscription price. You get the power of the most comprehensive cancer research coverage in the industry at a great discount.
Start today, and eliminate all those hours you normally spend scanning dozens of periodicals, websites, and other information sources. We've done it for you; we've got you covered.
|
2008